A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
Status:
Terminated
Trial end date:
2024-04-05
Target enrollment:
Participant gender:
Summary
A Phase 2 study to determine the safety and preliminary efficacy of intravitreal injections
of AVD-104, a novel glyco-mimetic nanoparticle, in reducing macular edema associated with
diabetic retinopathy.